Ledger.Open graph →
SEC Form D · Amendment · filed November 1, 2013

CymaBay Therapeutics, Inc

Offering
$45.0M
Sold
$30.2M
Exemption
Rule 506(c)
Industry
Biotechnology
Location
HAYWARD, CA
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (16)

Sujal Shah · Hayward, CAExecHarold Van Wart, Ph. D · Hayward, CAExec · DirectorKurt Von Emster · Hayward, CADirectorCharles A. Mcwherter, Ph. D · Hayward, CAExecLouis G. Lange, M.D., Ph.D · Hayward, CADirectorHari Kumar, Ph.D · Hayward, CADirectorEdward E. Penhoet, Ph.D · Hayward, CADirectorCarl Goldfischer, M.D · Hayward, CADirectorJace G. Simmons · WEST PALM BEACH, FLExec · DirectorThomas F. Mendolia · WEST PALM BEACH, FLExecSharon L. Hollis · WEST PALM BEACH, FLExecBryan Mclaren · Scottsdale, AZDirectorFrancis Kwok · SYDNEY, Channel IslandsDirectorElizabeth O'Leary · SYDNEY, Channel IslandsDirectorCooper H. Bane · Charleston, SCDirectorElliott G. Allen · Charleston, SCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗